Genmab

Last updated: June 04, 2024

Founder Don Drakeman
Founder Don Drakeman
Denmark | Funding: $204.3M (+)

Website: http://www.genmab.com/

Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer.